In T2DM, competitive binding of high insulin concentrations and amyloid β peptides with this enzyme could be involved in decreased amyloid β clearance, thereby potentially contributing to increased accumulation of amyloid β peptides, and formation of amyloid β plaques [15, 30, 31]. The gene discussed is INS; the disease is type 2 diabetes mellitus.